SUM-159PT cells: a novel estrogen independent human breast cancer model system Louise FlanaganKathryn Van WeeldenJoEllen Welsh OriginalPaper Pages: 193 - 204
The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer Elyse E. LowerRobbin BlauDonna L. Stahl OriginalPaper Pages: 205 - 210
Quantitation of erbB-2 gene copy number in breast cancer by an improved polymerase chain reaction (PCR) technique, competitively differential PCR Guoren DengYoung S. Kim OriginalPaper Pages: 211 - 215
Influence of estrogen receptor variants on the determination of ER status in human breast cancer Aihua HuangEtienne LeyguePeter H. Watson OriginalPaper Pages: 217 - 223
Sex hormone-induced mammary carcinogenesis in female Noble rats: Expression of TGF-β1 and its receptors, TGF-α, and EGF-R in mammary carcinogenesis B. XieS.W. TsaoY.C. Wong OriginalPaper 01 December 1999 Pages: 227 - 239
Changes associated with delay of mammary cancer by retinoid analogues in transgenic mice bearing c-neu oncogene Ghanta N. RaoElizabeth NeyRonald A. Herbert OriginalPaper Pages: 239 - 252
Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro Michael D. WalshStuart M. LuckieMichael A. McGuckin OriginalPaper Pages: 253 - 264
Expression of the estrogen receptor-associated immunophilins, cyclophilin 40 and FKBP52, in breast cancer Bryan K. WardPeter J. MarkThomas Ratajczak OriginalPaper Pages: 265 - 278
Symptoms associated with oophorectomy and tamoxifen treatment for breast cancer in premenopausal Vietnamese women Richard R. LoveNguyen Ba DucThomas C. Havighurst OriginalPaper Pages: 279 - 284
MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma Anne Talvensaari-MattilaPaavo PääkköTaina Turpeenniemi-Hujanen OriginalPaper Pages: 285 - 291
Reproductive factors in hereditary breast cancer Helena C.B. JernströmOskar T. JohannssonHåkan Olsson OriginalPaper Pages: 293 - 299
